Impact of Different Emergency Treatment Methods on Prognosis of Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Retrospective Study
DOI:
https://doi.org/10.59958/hsf.7511Keywords:
emergency treatment methods, prognosis, acute myocardial infarction, percutaneous coronary interventionsAbstract
Purpose: This study aimed to investigate the impact of different emergency treatment methods on the prognosis of patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). Methods: A retrospective study was conducted involving 114 patients admitted to the hospital between January 2022 and December 2022. The patients were divided into two groups based on their emergency treatment methods: First Transport and Then Treatment Group (n = 56) and Treatment Before Transport Group (n = 58). Baseline characteristics, biomarker levels, echocardiographic findings, curative effects, and 1-year follow-up outcomes were compared between the two groups. Results: Biomarker levels and echocardiographic parameters differed significantly between the two groups, thus indicates potential variations in disease severity and prognosis. Moreover, the 1-year follow-up outcomes showed higher rates of all-cause mortality (16.07% vs. 3.45%, p = 0.022), recurrent myocardial infarction (19.64% vs. 5.17%, p = 0.019), rehospitalization for cardiovascular causes (25.05% vs. 8.62%, p = 0.019), and PCI for new lesions (23.21% vs. 6.92%, p = 0.014) in the First Transport and Then Treatment Group compared with the Treatment Before Transport Group. Conclusion: The timing of emergency treatment methods in patients with AMI undergoing PCI appeared to significantly impact clinical outcomes, echocardiographic parameters, and 1-year follow-up outcomes. Immediate administration of treatment before transport showed potential benefits in mitigating myocardial damage and improving long-term prognosis compared with the approach of transporting the patient to the healthcare facility before initiating treatment.
References
Capaccione KM, Leb JS, D’souza B, Utukuri P, Salvatore MM. Acute myocardial infarction secondary to COVID-19 infection: A case report and review of the literature. Clinical Imaging. 2021; 72: 178–182.
Frampton J, Ortengren AR, Zeitler EP. Arrhythmias After Acute Myocardial Infarction. The Yale Journal of Biology and Medicine. 2023; 96: 83–94.
Gédéon T, Akl E, D’Souza R, Altit G, Rowe H, Flannery A, et al. Acute Myocardial Infarction in Pregnancy. Current Problems in Cardiology. 2022; 47: 101327.
Henry TD, Tomey MI, Tamis-Holland JE, Thiele H, Rao SV, Menon V, et al. Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2021; 143: e815–e829.
Kapur NK, Thayer KL, Zweck E. Cardiogenic Shock in the Setting of Acute Myocardial Infarction. Methodist DeBakey Cardiovascular Journal. 2020; 16: 16–21.
Khan U, Petrechko O, Sagheer S, Majeed H, Zaidi SH, Wasty N, et al. Acute Pancreatitis and Myocardial Infarction: A Narrative Review. Cardiology. 2023; 148: 1–11.
Edupuganti MM, Ganga V. Acute myocardial infarction in pregnancy: Current diagnosis and management approaches. Indian Heart Journal. 2019; 71: 367–374.
Krittanawong C, Khawaja M, Tamis-Holland JE, Girotra S, Rao SV. Acute Myocardial Infarction: Etiologies and Mimickers in Young Patients. Journal of the American Heart Association. 2023; 12: e029971.
Shah AH, Puri R, Kalra A. Management of cardiogenic shock complicating acute myocardial infarction: A review. Clinical Cardiology. 2019; 42: 484–493.
Gulati R, Behfar A, Narula J, Kanwar A, Lerman A, Cooper L, et al. Acute Myocardial Infarction in Young Individuals. Mayo Clinic Proceedings. 2020; 95: 136–156.
Thiele H, Zahn R. Acute myocardial infarction-actual issues. Herz. 2020; 45: 507–508. (In German)
Zeymer U. Diagnosis and initial management of acute myocardial infarction. MMW Fortschritte Der Medizin. 2019; 161: 34–36. (In German)
Akbari T, Al-Lamee R. Percutaneous Coronary Intervention in Multi-Vessel Disease. Cardiovascular Revascularization Medicine: Including Molecular Interventions. 2022; 44: 80–91.
Angiolillo DJ, Galli M, Collet JP, Kastrati A, O’Donoghue ML. Antiplatelet therapy after percutaneous coronary intervention. EuroIntervention: Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2022; 17: e1371–e1396.
Assali M, Buda KG, Megaly M, Hall AB, Burke MN, Brilakis ES. Update on chronic total occlusion percutaneous coronary intervention. Progress in Cardiovascular Diseases. 2021; 69: 27–34.
Azzalini L, Karmpaliotis D, Santiago R, Mashayekhi K, Di Mario C, Rinfret S, et al. Contemporary Issues in Chronic Total Occlusion Percutaneous Coronary Intervention. JACC. Cardiovascular Interventions. 2022; 15: 1–21.
Case BC, Wallace R. Editorial: No confusion where percutaneous coronary intervention may lead. Cardiovascular Revascularization Medicine: Including Molecular Interventions. 2023; 57: 68–69.
Eleid MF, Gulati R. Robotic Percutaneous Coronary Intervention: Making Gains With Experience. Circulation. Cardiovascular Interventions. 2020; 13: e009237.
Dauerman HL, Ibanez B. The Edge of Time in Acute Myocardial Infarction. Journal of the American College of Cardiology. 2021; 77: 1871–1874.
Egorova TV, Khodareva EN, Ruda MI, Sergienko VB. Effect of restoration of coronary blood flow on dynamics of myocardial perfusion and function in patients with acute myocardial infarction. Data of gated technetium-99m-sestamibi SPECT. Kardiologiia. 2003; 43: 17–21.
Prasad A, Gersh BJ, Mehran R, Brodie BR, Brener SJ, Dizon JM, et al. Effect of Ischemia Duration and Door-to-Balloon Time on Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction: An Analysis From HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction). JACC. Cardiovascular Interventions. 2015; 8: 1966–1974.
Ott I, Schulz S, Mehilli J, Fichtner S, Hadamitzky M, Hoppe K, et al. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial. Circulation. Cardiovascular Interventions. 2010; 3: 408–413.
Graham LN, Smith PA, Stoker JB, Mackintosh AF, Mary DASG. Time course of sympathetic neural hyperactivity after uncomplicated acute myocardial infarction. Circulation. 2002; 106: 793–797.
Zhou M, Yu K, Wang XH, Yang CS, Lei YP, Wang YG, et al. Analysis on application timing of IABP in emergency PCI treatment of patients with combined acute myocardial infarction and cardiac shock. European Review for Medical and Pharmacological Sciences. 2017; 21: 2934–2939.
Chen B, Wen J, You D, Zhang Y. Implication of cognitive-behavioral stress management on anxiety, depression, and quality of life in acute myocardial infarction patients after percutaneous coronary intervention: a multicenter, randomized, controlled study. Irish Journal of Medical Science. 2024; 193: 101–109.
